Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ligand Pharmaceuticals

108.07
-0.4800-0.44%
Post-market: 108.070.00000.00%19:41 EDT
Volume:102.96K
Turnover:11.00M
Market Cap:2.08B
PE:-490.23
High:108.34
Open:106.95
Low:104.65
Close:108.55
Loading ...

Press Release: Palvella Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update

Dow Jones
·
31 Mar

Barclays Keeps Their Buy Rating on Ligand Pharma (LGND)

TIPRANKS
·
10 Mar

Top March 2025 Stocks Estimated To Be Trading Below Their Intrinsic Value

Simply Wall St.
·
08 Mar

Stock Track | Ligand Pharmaceuticals Plunges 5.06% as 2024 Results and Acquisition Come Under Scrutiny

Stock Track
·
03 Mar

Ligand to Participate in March Investor Conferences

GlobeNewswire
·
03 Mar

LGND: First Steps into Cell & Gene Therapy

Zacks Small Cap Research
·
03 Mar

Ligand Pharmaceuticals’ Earnings Call Highlights Strong Growth

TIPRANKS
·
01 Mar

Stock Track | Ligand Pharmaceuticals Soars 5.07% on Strong Earnings, New Product Launches, and Positive Outlook

Stock Track
·
01 Mar

Ligand Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
28 Feb

RBC Raises Price Target on Ligand Pharmaceuticals to $155 From $143, Keeps Outperform Rating

MT Newswires Live
·
28 Feb

Ligand Pharmaceuticals Inc (LGND) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com
·
28 Feb

Ligand Pharmaceuticals Reports Strong 2024 Financial Growth

TIPRANKS
·
28 Feb

Ligand Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

Stock Track | Ligand Pharmaceuticals Soars 6.32% on Thursday Following Q4 Earnings Beat and Upbeat 2025 Guidance

Stock Track
·
27 Feb

Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR), Madrigal Pharmaceuticals (MDGL) and Ligand Pharma (LGND)

TIPRANKS
·
27 Feb

Ligand Pharmaceuticals' Q4 Core Adjusted Net Income, Total Revenue Rise; 2025 Guidance Set

MT Newswires Live
·
27 Feb

Craig-Hallum Reaffirms Their Buy Rating on Ligand Pharma (LGND)

TIPRANKS
·
27 Feb

Ligand: Q4 Earnings Snapshot

Associated Press Finance
·
27 Feb

Ligand Pharmaceuticals Q4 2024 Adj EPS $1.27 Beats $1.19 Estimate, Sales $42.81M Beat $39.02M Estimate

Benzinga
·
27 Feb

BRIEF-Ligand Pharmaceuticals Q4 EPS USD -1.64

Reuters
·
27 Feb